The global surface disinfectant market was valued USD 2,598.3 million in 2023, which is expected to reach USD 4,786.7 million by 2030, progressing with a CAGR of 9.3% during 2024–2030. This is attributed to the rise in the prevalence of infectious diseases and positive impact of COVID-19 on the market. For instance, a study published in the Elsevier Public Health Emergency Collection on August 2021 concluded a significant increase in household disinfectant consumption in China due to the COVID-19 pandemic.
Moreover, the changing lifestyle in developing countries, rising awareness about overall hygiene, and increasing demand for disinfectants for use in hospitals are expected to boost the market growth during the forecast period.
The alcohol category accounted for the largest market share in 2023 because of the high efficacy of alcohol-based disinfectants against bacteria and viruses. In addition, it was found in a China-based study that since COVID-19 broke out, alcohol-based disinfectants have been preferred for hand sanitization and home disinfection. Furthermore, the WHO also recommends alcohol-based formulations. In a study, two alcohol-based hand rub solutions were able to significantly deactivate the monkeypox virus.
Instrument disinfection is expected to witness a significant CAGR during 2024–2030, based on application. Medical instruments, such as catheters, ventilators, and probes, need disinfection before every use. Moreover, the analytical instruments used in clinical laboratories for analysis must be disinfected to remove microorganisms.
Hospitals are dominating end user segment because people with infections mostly come to hospitals, and surgeries are also majorly performed here. Moreover, the growing awareness of HAIs, especially after the COVID-19 outbreak, is expected to add to hospitals’ demand for disinfectants.
North America held the largest share, of around 55%, in 2023, and it is expected to grow at a significant CAGR during 2024–2030. In September 2022, Parker Laboratories Inc. entered into a commercial partnership with infection prevention company Tristel Solutions Limited to distribute and manufacture the company's disinfectant foams across the U.S. According to the contract, Parker will manufacture and distribute Tristel DUO, a disinfecting foam for the disinfection and cleaning of general medical surfaces.
Companies are also distributed disinfectants for population health management. For instance, Medline Industries Inc. donated disinfectant wipes and sanitizer with a total market value of more than USD 2 million to an NGO working for low-income communities in the Mississippi Delta and people in Puerto Rico and Florida affected by hurricanes Ian and Fiona.
Moreover, in March 2020, Neogen Corporation announced that it is ramping up its inventory of disinfectant wipes, hand sanitizers, nitrile gloves, and disinfectants to help in the global effort to slow the spread of COVID-19. Neogen’s comprehensive suite of biosecurity products includes cleaners, sanitizers, and disinfectants. The company also offers AccuPoint Advanced, a monitoring device that provides an indication of the cleanliness of a surface.
Canada also holds a significant share in the market, attributed to the receipt of market authorization for numerous products by market players in the country. For instance, in August 2022, Voran Group Ventures Ltd. announced the receipt of the market authorization from Health Canada for disinfectant solution Bacoban (106).
Some of the key players operating in the market are Reckitt Benckiser Group Plc, Ecolab Inc., The Clorox Company, Diversey Inc., Metrex Research LLC, Medline Industries, GOJO Industries Inc., Brulin Holding Company Inc., GESCO Healthcare Pvt. Ltd., and Paul Hartmann AG.